These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1126142)

  • 1. [On a new trial therapy of progressive muscular dystrophy].
    Costagliola A; Di Lorenzo S
    Clin Ter; 1975 May; 73(3):251-9. PubMed ID: 1126142
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complamine in combination with methionine in the treatment of parapsoriasis].
    Orazymbetova ZhA
    Vestn Dermatol Venerol; 1978 Mar; (3):65-8. PubMed ID: 654516
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prolonged clinical study of the LA, 313-B-xanthinol niacinate pentosan sulfonate ester combination in various forms of hypertension].
    Masso M; Gimeno Martínez J; Honorato J
    Rev Clin Esp; 1976 Jul; 142(2):157-61. PubMed ID: 968103
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic results with xanthine derivatives in the intermittent claudication syndrome in diabetic patients].
    Gómez Reyes D; Rojas Hidalgo E
    Rev Clin Esp; 1988 Jan; 182(1):3-6. PubMed ID: 3375512
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trial of xanthinol nicotinate in delayed form in the treatment of arteritis of the lower limbs].
    Niquet G; Dupont T
    Lille Med; 1976 Jan; 21(1 suppl 1):13-5. PubMed ID: 1256225
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug therapy of hyperlipemia. Experiences with xanthinol nicotinate retard-capsules in a general practice].
    Klimm HD
    Med Monatsschr; 1976 Apr; 30(4):178-80. PubMed ID: 958145
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness of the local use of komplamin and ATP in treating patients with primary and secondary optic atrophy].
    Shpak NI; Fedorova LI; Savko VV; Konovalova NV
    Oftalmol Zh; 1985; (3):159-62. PubMed ID: 4011098
    [No Abstract]   [Full Text] [Related]  

  • 8. [Taurine in the treatment of ischemic cardiopathies and of progressive muscular dystrophy].
    Nigro G; Comi LI; Loiudice A; Petretta V
    Clin Ter; 1971 Feb; 56(4):347-59. PubMed ID: 5581069
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypolipidaemic effect of xantinol nicotinate: a clinical trial.
    Dhorranintra B; Khunawat P; Patalung BN; Prabhan C
    J Med Assoc Thai; 1983 May; 66(5):269-73. PubMed ID: 6348198
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of fenicaberan and xavin on peripheral hemodynamic and blood coagulability indices in patients with chronic ischemic heart disease].
    Shpak BIu; Neĭko EM; Debenklo MV; Lazho AS; Duma ZV
    Vrach Delo; 1988 Mar; (3):34-6. PubMed ID: 3394293
    [No Abstract]   [Full Text] [Related]  

  • 11. [Xanthinic derivatives in the treatment of intermittent claudication syndrome in diabetic patients].
    Gómez Reyes D; Rojas Hidalgo E
    Rev Clin Esp; 1986 Jul; 179(3):162. PubMed ID: 3764000
    [No Abstract]   [Full Text] [Related]  

  • 12. Favourable effect of combined Miscleron-Xavin treatment on HDL-cholesterol level.
    Pados G; Kusztos D; Németh-Csóka M; Valyon M; Farkas K
    Ther Hung; 1983; 31(2):59-61. PubMed ID: 6571183
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of hyperlipidemia with xanthinol nicotinate as opposed to low fat diet].
    Baumann J; Martschick R
    Med Welt; 1982 Jan; 33(4):139-41. PubMed ID: 7062844
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of teonikol and trental in the combined treatment of patients with suppurative surgical infection and concomitant diabetes mellitus].
    Nuzov BG
    Klin Med (Mosk); 1985 Dec; 63(12):73-8. PubMed ID: 4094394
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative effectiveness of the local use of sodium nitrite, platyphylline and complamine in treating optic atrophy].
    Shpak NI; Salenko SV
    Oftalmol Zh; 1984; (5):294-7. PubMed ID: 6504461
    [No Abstract]   [Full Text] [Related]  

  • 16. [Complamin in the complex therapy of patients with chronic nonspecific prostatitis].
    Iunda IF; Israilov SR
    Vrach Delo; 1987 Nov; (11):64-7. PubMed ID: 3439130
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of a long-term study on the therapeutic effectiveness of xanthinol nicotinate in chronic hepatopathies].
    Dohrmann RE; Kessel ME
    Z Allgemeinmed; 1975 Sep; (26):1167-72. PubMed ID: 1226797
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of Xavin infusions in obliterating peripheral arterial disorders.
    Keller L; Landi A; Bársony J
    Ther Hung; 1975; 23(2):54-9. PubMed ID: 1188703
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ergometric evaluation of treatment of ischemic heart disease with xavine].
    Zadionchenko VS; Vertkin AL; Martynov AI; Panchenkova LA; Troshina EV
    Sov Med; 1978 Jan; (1):68-73. PubMed ID: 635674
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of complamin and prodectin on microcirculation and lipid metabolism in psoriasis patients].
    Rakhmatov AB; Bilash NV
    Vestn Dermatol Venerol; 1983 Apr; (4):15-8. PubMed ID: 6868813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.